A key protein, LRG1, was identified as the early cause of diabetic eye damage, and blocking it may stop the disease before ...

November marks Diabetic Eye Disease Awareness Month, highlighting the silent vision risks of diabetes and the importance of ...

Gemma Collins has revealed she had to stop taking weight-loss injections after suffering a "gallbladder attack" the could ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...

The pharmaceutical giant Eli Lilly's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and ...

Diabetes is a systemic disease, which means it affects many organs, including the heart, blood vessels, nerves, kidneys and ...

According to Precedence Research, the global tubeless insulin pump market size will grow from USD 2.92 billion in 2025 to nearly USD 13.65 billion by 2034, with an expected CAGR of 18.74% from 2025 to ...

Four patients in Denmark, who experienced vision loss after using Novo Nordisk's popular weight-loss and diabetes drugs ...

A long-time supporter of the St John Eye Van, UD Trucks has been formally recognised for its support of the vital regional ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

FDA approves Regeneron's Eylea HD for retinal vein occlusion, adding extended dosing options and greater flexibility across ...